Posts

October 13, 2014

+
2:37 PM | FDA approves first combination pill to treat hepatitis C
The U.S. Food and Drug Administration has  approved Harvoni (ledipasvir and […]
+
2:36 PM | Scientists sniff out unexpected role for stem cells in the brain
For decades, scientists thought that neurons in the brain were […]
+
2:33 PM | Want whiter teeth? Fruit mixture is not the answer
Can you ditch the strips and dump the dentist for […]
+
2:31 PM | Solid nanoparticles can deform like a liquid
A surprising phenomenon has been found in metal nanoparticles: They […]
+
2:31 PM | Single gene links susceptibility to rare infections with predisposition to autoimmune disease
The mutations were familiar, but the patients’ conditions seemed baffling […]
+
2:11 PM | Lentils in Salads, Pilafs and Pies
This is one legume you should always have in your larder.
+
1:47 PM | VIDEO: The role of artificial intelligence in healthcare
IBM's Amer Fasihi explains the impact its supercomputer Watson could have on health
+
11:46 AM | IBM: Watson can make the world a better place
ThinkDigital event hears how the supercomputer could improve people' lives
+
11:08 AM | Commissioning Support Units: Their progress so far
The Health Service Journal has published this supplement to highlight the successes of Commissioning Support Units (CSUs), and to discuss their next steps, as they “enter a competitive market next year”, where they have to bid to get a place on the lead provider framework. There has been immense change since CSUs were first launched, [read the full story...]
+
10:54 AM | Gilead gets US approval for Sovaldi follow-up Harvoni
Company claims it could cure 90% of patients within eight weeks
+
9:59 AM | NICE publishes its first medicines optimisation guidance
Draft guidelines encourage patient-centred care and improved NHS communications
+
9:11 AM | EMA safety panel rules no change needed for Ariad's Iclusig
Positive news comes after blood clot concerns
+
8:13 AM | Study Alert: The Health Consequences of Sex Trafficking and Their Implications for Identifying Victims in Healthcare Facilities
By Sharon E. ChinCan victims of sex trafficking be identified?The usefulness of training U.S. healthcare providers to identify victims of human trafficking has long been debated. As ongoing – slim – research reveals more information about shared characteristics and symptoms among victims, the debate is understandable. Are health providers coming into contact with victims? Would the use of current anti-trafficking efforts be most optimized by including training for health providers? […]
+
7:19 AM | Evidence Update: Preventing type 2 diabetes at the population and community level
With the rate at which new evidence is published, it’s impossible for guidelines or even systematic reviews to keep pace.  That’s why NICE Evidence Updates are so, err, nice!  They summarise what’s new in relation to existing NICE guidelines since they were published. The NICE guidance This Evidence Update relates to NICE guideline 35 on [read the full story...]
+
7:00 AM | Andrew Wakefield, the MMR, and a “mother warrior’s” fabricated vaccine injury story
As the time came to do my usual weekly post for this blog, I was torn over what to write about. Regular readers might have noticed that a certain dubious cancer doctor about whom I’ve written twice before has been agitating in the comments for me to pay attention to him, after having sent more […]
+
6:30 AM | Reducing benzodiazepine prescribing in primary care
Liz Hughes summarises two recent studies (1 systematic review and 1 RCT) that both investigate brief interventions for reducing the use of benzodiazepines in primary care. The post Reducing benzodiazepine prescribing in primary care appeared first on The Mental Elf.
+
5:00 AM | Unapproved Synthetic Stimulant Found in Multiple Dietary Supplements
DMBA chemical structure similar to other banned stimulants DMAA and Ephedrine.
+
5:00 AM | Industry Coalition: Dietary Supplements Cannot Claim to Cure, Prevent Ebola
No scientific data supports the use of dietary supplements to prevent or treat Ebola.
+
5:00 AM | Demand for Natural Sweeteners on the Rise
Canadean report predicts consumer demand for non-caloric sweeteners to grow 5% a year until 2017.
+
5:00 AM | Healthy Lifestyle May Cut Stroke Risk in Half for Women
Women who had a healthier diet were 13% less likely to have a cerebral infarction than those whose diet was not as healthy.
+
5:00 AM | Study Shows Consumers Want More Omega-3
Research highlights changing attitudes about fats and oils.
+
5:00 AM | Sales Growth for CPG Companies Coming from Lower-Calorie Foods
Major food and beverage companies answering demand for lower calorie products.
+
5:00 AM | Half of U.S. Consumers Consider Animal Protein the Best Source of Protein
Beef and chicken, followed by fish, top the list of animal proteins considered the best, according to an NPD Group report.
+
4:59 AM | Intravenous midazolam sedation for dental treatment: review found no significant side effects
This review of IV midazolam for treating children and adolescents only identified 11 studies (5 RCTs, 6 non randomised). No serious adverse events were reported but there was a generalised inconsistency in side effect reporting. Consequently the call for better side effect reporting. The post Intravenous midazolam sedation for dental treatment: review found no significant side effects appeared first on The Dental Elf.
+
1:25 AM | Public Health in the News – October 12, 2014
Global HIV-positive individuals may end up needing new organs due to health issues, but they are not eligible for organ transplants. Now, a South African doctor is transplanting organs that have been donated from other HIV-positive patients. The Nobel Prize … Continue reading →

October 12, 2014

+
11:15 PM | Eisai wins US approval for chemotherapy side effects drug
FDA backs Akynzeo to treat nausea and vomiting
+
11:15 PM | Sanofi looks to AstraZeneca for new UK & Ireland head
Tarja Stenvall replaces Steve Oldfield
+
11:03 PM | Pharma deals during September 2014
Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month
+
11:02 PM | Deal Watch table for September 2014
Table listing all the major pharma mergers, acquisitions and collaborations in the past month
+
3:58 PM | Withdrawal Work-Up II
First posted 11/11/2012 In my last post, I wrote about the work-up of a patient who experiences symptoms similar to opioid withdrawal that start about an hour after each dose of Suboxone.  We decided that the symptoms were signs of withdrawal—i.e. reduced activity of mu-opioid pathways—and that the symptoms were triggered by taking a daily […]
5678910111213
638 Results